All articles by Sofia Karadima
Sofia Karadima is a senior editor and researcher at Investment Monitor, focusing on financial and business services, and ESG investing. She previously covered institutional investment across private markets for financial news and research provider Acuris. She has reported on private equity, venture capital, private debt and infrastructure, among other topics. Sofia is currently based in London, after living in Chile, Denmark, Spain and Greece.
Sofia Karadima
The three cross-border M&A deals that shaped healthcare in 2022
Investment Monitor has identified three cross-border M&A deals within the healthcare sector that stood out in 2022.
The three cross-border M&A deals that shaped the construction sector in 2022
Investment Monitor has identified three cross-border M&A deals within the construction sector that stood out in 2022.
The five cross-border M&A deals that shaped the retail sector in 2022
Investment Monitor has identified five cross-border M&A deals within the retail sector that stood out in 2022.
The five cross-border M&A deals that shaped financial services in 2022
Investment Monitor has identified the five cross-border M&A deals within financial services that stood out in 2022.
Is Turkey using FDI to increase its influence in Africa?
Turkey started to actively increase its engagement with Africa in 2005, which has seen FDI inflows into the continent rise.
The US edges out Singapore as top country for overseas business expansions
The US ranks as the top country for overseas business expansions followed by Singapore and Ireland, according to a study by Remote.
What trends are set to drive demand for investment in the next decade?
The need for energy independence, manufacturing capacity and a green transition will shape investment trends over the next decade.
Mile high and rising: How diversification is paying off for Denver
A favourable geographic location, an educated workforce, strong connectivity and a high quality of life are working in Denver’s favour when it comes to attracting investment.
CRO consolidation: is the clinical trials industry reaching a tipping point?
The M&A trend among CROs and clinical service providers raises questions about sustainability and impact on their pharma clients.
HSBC ads ban increases greenwashing scrutiny of UK banking sector
Will a ban by a UK regulator on HSBC ads over greenwashing claims see a move to greater transparency in banking sector advertising?